Criteria for Hidradenitis Suppurativa Competence Centers
INTRODUCTION: Hidradenitis suppurativa (HS) is a chronic, systemic, immune-mediated disease requiring multimodal care, which is crucial for raising awareness and advancing treatment. This project aimed to establish consensus among HS experts to define HS Competence Centers (HSCC) criteria using the Delphi consensus method. METHODS: Overall, 22 global HS experts (3 patient representatives and 19 healthcare professionals [HCPs]) from 16 countries across 5 continents were invited to participate. Subsequently, a three-step Delphi polling was conducted among the HS experts from 20 May 2024 to 8 July 2024. A 50% agreement was required to reach consensus. Consensus levels included strong consensus (≥ 95%), consensus (≥ 75%), majority agreement (≥ 50%) and no majority agreement (< 50%). RESULTS: In the prepolling step, 22 participants proposed 26 criteria. In step 1, 23 criteria were selected, of which 6 (23.1%) reached strong consensus, 11 (42.3%) reached consensus, and 6 (23.1%) majority agreement. The remaining 3 (11.5%) criteria proposed were rejected. In step 2, 13 of the 23 criteria (56.5%) were proposed for wording modifications. Of these, four (30.8%) retained initial wording and nine (69.2%) were modified. In step 3, 21 of the 23 criteria were identified as very important (91.3%), while 2 (8.7%) were considered less important. Among the 21 very important criteria, 2 (9.5%) reached strong consensus, i.e., essential, 12 (57.1%) reached consensus, and 7 (33.4%) had majority agreement. Overall, a set of 23 criteria (2 essential, 12 required-1st grade, 7 required-2nd grade, and 2 potential) was recommended to establish HSCC. CONCLUSIONS: This article reveals a consensus among an international group of HCPs and patients on a series of evidence-based criteria for HSCC. Standardized care, a hub and spoke model, multidisciplinary teams, specialized treatments, well-defined protocols, patient education, medical training, and robust referral systems were identified as essential/very important criteria for HSCC.
Authors
- Ichiro Kurokawa (ORCID: https://orcid.org/0000-0002-1440-5178)
- Wayne Gulliver (ORCID: https://orcid.org/0000-0002-5990-232X)
- John W. Frew (ORCID: https://orcid.org/0000-0001-5042-3632)
- Nisha Suyien Chandran (ORCID: https://orcid.org/0000-0001-8225-0035)
- G. Pintori
- Thrasyvoulos Tzellos (ORCID: https://orcid.org/0009-0004-5110-4077)
- Maria Cecilia Rivitti-Machado
- Nicolas Thomas
- Falk G. Bechara
- Barry M. McGrath
- Axel P. Villani
- Ximena Wortsman (ORCID: https://orcid.org/0000-0003-3359-5023)
- Hessel H. Van der Zee
- Valeria Jordan
- Qiang Ju
- Angelo V. Marzano (ORCID: https://orcid.org/0000-0002-2258-8357)
- Antonio Martorell
- Afsaneh Alavi
- Christos C. Zouboulis (ORCID: https://orcid.org/0000-0003-1646-2608)
- Christopher J. Sayed
- Ivette Alarcon
- Jennifer L. Hsiao
- John R. Ingram
- Vivian Y. Shi
Institutions
- Université Claude Bernard Lyon 1 (FR)
- University of North Carolina at Chapel Hill (US)
- University of Southern California (US)
- Novartis (Switzerland) (CH)
- Memorial University of Newfoundland (CA)
- National University of Singapore (SG)
- University of Milan (IT)
- University of Washington (US)
- University Hospitals of the Ruhr-University of Bochum (DE)
- Renji Hospital (CN)
- Liverpool Hospital (AU)
- Nordland Hospital Trust (NO)
- Erasmus MC (NL)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- UNSW Sydney (AU)
- Hospices Civils de Lyon (FR)
- Hospital de Manises (ES)
- Presidio Ospedaliero (IT)
- Mayo Clinic in Arizona (US)
- Ingham Institute (AU)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- National University Hospital (SG)
- Hyogo Prefectural Nishinomiya Hospital (JP)
- Hidradenitis Suppurativa Foundation (US)
- University of Chile (CL)
- Cardiff University (GB)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-05-23
- DOI
- https://doi.org/10.1007/s13555-026-01783-1
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novartis Pharma